NYSE: MAXMediaalpha Inc Stock
$10.50+0.10 (+0.96%)
Updated Jul 3, 2025
MAX Price
$10.50
Fair Value Price
N/A
Market Cap
$708.43M
52 Week Low
$7.33
52 Week High
$20.91
P/E
37.5x
P/B
89.46x
P/S
0.51x
PEG
0.44x
Dividend Yield
N/A
Revenue
$1.00B
Earnings
$15.79M
Gross Margin
16.1%
Operating Margin
3.05%
Profit Margin
1.6%
Debt to Equity
35.51
Operating Cash Flow
$68M
Beta
1.28
Next Earnings
Jul 29, 2025
Ex-Dividend
N/A
Next Dividend
N/A
MAX Overview
MediaAlpha Incorporated offer an online customer acquisition platform that brings insurance carriers and consumers together in a real-time ecosystem. The platform has a set of predictive analytics algorithms that generate conversion probabilities for each unique consumer. It allows buyers to fully integrate first-party consumer data to enhance targeting parameters, bidding granularity and conversion tracking. MediaAlpha was founded in 2014 and is headquartered in Los Angeles, CA.
Zen Rating
Our proven quant model uses 115 proprietary factors, including AI, to determine MAX's potential to beat the market
BBuy
- Stocks with a Zen Rating of Buy (B) had an average return of +19.88% per year. Learn More
Zen Rating Component Grades
C
Zen Rating uses advanced AI algorithms that detect subtle patterns in market data; it anticipates future trends that point to superior stock price results.
Industry: Internet Content & Information
Industry Rating
B
MAX
Ranked#13 of 51
Ranked#13 of 51
Top Ranked Stocks in Industry
| Name / Ticker | Price | Zen Rating |
|---|---|---|
| $24.53 | A | |
| $11.32 | A | |
| $18.32 | A |
Be the first to know about important MAX news, forecast changes, insider trades & much more!
MAX News
Overview
Due Diligence Score
–
Industry Average (28)
You've viewed Due Diligence Score for 10/10 free stocks. Upgrade to Premium to see how MAX scored across 33 valuation, financial, forecast, performance, and dividend due diligence checks.
Due Diligence Checks
MAX ($10.50) is trading above its intrinsic value of $10.05, according to an updated version of Benjamin Graham's Formula from Chapter 11 of "The Intelligent Investor"
Below Benjamin Graham Formula Value Valuation
MAX is poor value based on its earnings relative to its share price (37.5x), compared to the US market average (30.96x)
P/E vs Market Valuation
MAX is poor value based... subscribe to Premium to read more.
P/E vs Industry Valuation
There are 30 more MAX due diligence checks available for Premium users.
Valuation
MAX price to earnings (PE)
For valuing profitable companies with steady earnings
Company
37.5x
Industry
28.81x
Market
30.96x
MAX is poor value based... subscribe to Premium to read more.
P/E vs Industry Valuation
MAX is poor value based... subscribe to Premium to read more.
P/E vs Market Valuation
MAX price to book (PB)
For valuing companies that are loss-making or have lots of physical asset
Company
89.46x
Industry
6.88x
MAX is poor value based... subscribe to Premium to read more.
P/B vs Industry Valuation
MAX price to earnings growth (PEG)
For valuing profitable companies with growth potential
MAX is good value based... subscribe to Premium to read more.
PEG Value Valuation
MAX's financial health
Profit margin
Revenue
$264.3M
Net Income
-$1.9M
Profit Margin
-0.7%
MAX's Earnings (EBIT) of $30.56M... subscribe to Premium to read more.
Interest Coverage Financials
MAX's profit margin has increased... subscribe to Premium to read more.
Profit Margin Growth Financials
Assets to liabilities
Assets
$240.0M
Liabilities
$281.2M
Debt to equity
35.51
MAX's short-term assets ($182.47M) exceed... subscribe to Premium to read more.
Short-term Liabilities Financials
MAX's short-term assets ($182.47M) exceed... subscribe to Premium to read more.
Long-term Liabilities Financials
MAX's debt to equity ratio... subscribe to Premium to read more.
Healthy Debt to Equity Financials
Cash flow
Operating
$23.7M
Investing
-$57.0k
Financing
-$3.3M
MAX's operating cash flow ($67.90M)... subscribe to Premium to read more.
Debt Coverage Financials
MAX vs Internet Content & Information Stocks
Mediaalpha Stock FAQ
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.